Bioengineering · 2021 · 47 citations · 54 references
Life SciencesInfectious DiseasesMolecular BiologyMolecular DiagnosticsMolecular VirologyVirologyCrispr-cas SystemsInfectious Disease Molecular TestingPathogen DetectionRespiratory Pathogen DiagnosticsViral DiagnosticsCrispr DiagnosticsCrispr-based BiosensorsCrispr-based Molecular DiagnosticsCrispr-cas Target CleavageField Deployment TestingRespiratory Syncytial Virus Diagnostics
Clustered regularly interspaced short palindromic repeat (CRISPR/Cas) proteins can be designed to bind specified DNA and RNA sequences and hold great promise for the accurate detection of nucleic acids for diagnostics. We integrated commercially available reagents into a CRISPR/Cas9-based lateral flow assay that can detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequences with single-base specificity. This approach requires minimal equipment and represents a simplified platform for field-based deployment. We also developed a rapid, multiplex fluorescence CRISPR/Cas9 nuclease cleavage assay capable of detecting and differentiating SARS-CoV-2, influenza A and B, and respiratory syncytial virus in a single reaction. Our findings provide proof-of-principle for CRISPR/Cas9 point-of-care diagnosis as well as a scalable fluorescent platform for identifying respiratory viral pathogens with overlapping symptomology.
54
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jínek, Krzysztof Chylinski, Ines Fonfara et al. · Science · 2012 · 17.3K citations · Full text
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong, F. Ann Ran, David Cox et al. · Science · 2013 · 15.7K citations
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Janice S. Chen, Enbo Ma, Lucas B. Harrington et al. · Science · 2018 · 4.4K citations
CRISPR–Cas12-based detection of SARS-CoV-2
James P. Broughton, Xianding Deng, Guixia Yu et al. · Nature Biotechnology · 2020 · 2.8K citations · Full text
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Wenyan Jiang, David Bikard, David Cox et al. · Nature Biotechnology · 2013 · 2.5K citations